Best corrected visual acuity and maximum retinal thickness by visit, as well as number and timing of treatment sessions during study period
| Patient | Baseline | Week 1 | Week 12 | Week 48 | i-MP treatment sessions | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| BCVA | MRT | BCVA | MRT | BCVA | MRT | BCVA | MRT | Number | Study period | |
| BCVA = best corrected visual acuity (logMAR values); BSL = baseline; MRT = maximum retinal thickness (μm). | ||||||||||
| 1 | 1.34 | 343 | 1.22 | 290 | 1.22 | 312 | 1.2 | 316 | 1+1 | BSL+24 weeks |
| 2 | 1.52 | 441 | 1.22 | 298 | 1.18 | 262 | 1.18 | 269 | 1+0 | BSL |
| 3 | 1.04 | 390 | 0.8 | 284 | 0.68 | 271 | 0.78 | 251 | 1+1 | BSL+24 weeks |
| 4 | 1.3 | 364 | 1.32 | 368 | 1.3 | 380 | 1.34 | 399 | 1+1 | BSL+12 weeks |
| 5 | 1.22 | 295 | 1.08 | 266 | 1.04 | 251 | 1.14 | 258 | 1+1 | BSL+24 weeks |
| 6 | 1.16 | 321 | 1.14 | 308 | 1.12 | 326 | 1.14 | 313 | 1+1 | BSL+24 weeks |
| 7 | 1.2 | 388 | 1.2 | 375 | 1.28 | 390 | 1.42 | 452 | 1+3 | BSL+12+24+36 weeks |
| 8 | 1.44 | 502 | 1.22 | 359 | 1.16 | 305 | 1.12 | 288 | 1+0 | BSL |
| 9 | 1.32 | 487 | 1.24 | 352 | 1.2 | 349 | 1.2 | 320 | 1+1 | BSL+24 weeks |
| Mean | 1.28 | 392.33 | 1.16 | 322.22 | 1.13 | 316.22 | 1.17 | 318.44 | 1+1 | |
| ±1 SD | 0.146 | 71.746 | 0.150 | 41.184 | 0.186 | 50.079 | 0.177 | 67.024 | 0.866 | |